Claims for Patent: 5,075,224

Summary for Patent: 5,075,224

Title:	Prepro-LHRH C-terminal peptide DNA
Abstract:	DNA encoding a novel polypeptide hormone, designated CTP, has been identified in the human genome. CTP is expressed as a fusion protein (proLHRH) with luteinizing hormone releasing hormone (LHRH), and is post-translationally processed to CTP and LHRH. CTP, its derivatives, and its fusions, including proLHRH, are useful in therapy and diagnostics.
Inventor(s):	Seeburg; Peter H. (San Francisco, CA), Adelman; John P. (Eugene, OR)
Assignee:	Genentech, Inc. (South San Francisco, CA)
Application Number:	07/681,628
Patent Claims:	1. A method for synthesizing a polypeptide selected from the group of CTP and a fusion of CTP with another polypeptide, comprising: (a) transforming a host cell with a vector known to encode the polypeptide; (b) culturing the cell whereby the polypeptide is expressed; and (c) recovering CTP from the host cell culture or from the fusion of CTP with the second polypeptide. 2. The method of claim 1 wherein the fusion is with a microbial polypeptide bound to the N-terminus of CTP, or the tripeptide lys-lys-ile bound to the C-terminus of CTP. 3. The method of claim 2 wherein the microbial polypeptide is a bacterial signal operably linked to CTP. 4. The method of claim 7 wherein the fusion is with LHRH. 5. The method of claim 1 wherein the host cell is a yeast or bacterial cell. 6. The method of claim 1 wherein the polypeptide fused to CTP is free of proLHRH and LHRH. 7. The method of claim 1 wherein the synthesized polypeptide is CTP. 8. DNA encoding a polypeptide including a CTP amino acid sequence free of proLHRH, provided that the DNA is free of at least one intron when it encodes the polypeptide Met Lys Pro Ile Gln Lys Leu Leu Ala Gly Leu Ile Leu Leu Thr Ser Cys Val Glue Gly Cys Ser Ser Gln His Trp Ser Tyr Gly Leu Arg Pro Gly Gly Lys Arg Asp Ala Glu Asn Leu Ile Asp Ser Phe Gln Glu Ile Val Lys Glu Val Gly Gln Leu Ala Glu Thr Gln Arg Phe Glu Cy Thr Thr His Gln Pro Arg Ser Pro Leu Arg Asp Leu Lys Gly Ala Leu Glu Ser Leu Ile Glu Glu Glu Thr Gly Gln Lys Lys Ile. 9. DNA encoding a polypeptide including a CTP amino acid sequence free of proLHARH, provided that the DNA is extrachromosomal when it encodes the polypeptide Met Lys Pro Ile Gln Lys Leu Leu Ala Gly Leu Ile Leu Leu Thr Ser Cys Vel Glu Gly Cys Ser Ser Gln His Trp Ser Tyr Gly Leu Arg Pro Gly Gly Lys Arg Asp Ala Glu Asn Leu Ile Asp Ser Phe Gln Glu Ile Val Lys Glu Val Gly Gln Leu Ala Glu Thr Gln Arg Phe Glu Cys Thr Thr His Gln Pro Arg Ser Pro Leu Arg Asp Leu Lys Gly Ala Leu Glu Ser Leu Ile Glu Glu Glu Thr Gly Gln Lys Lys Ile. 10. The DNA of claim 9 which is operably ligated into a replicable vector. 11. A host cell transformed with the vector of claim 10.

Details for Patent 5,075,224

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2008-12-24
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2008-12-24
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2008-12-24